Herd Immunity and Implications for SARS-CoV-2 Control

Saad B Omer^{1

2}, Inci Yildirim^{1

3}, Howard P Forman^{4

5}

Affiliations

¹ Yale Institute for Global Health, New Haven, Connecticut.
² Departments of Internal Medicine and Epidemiology of Microbial Diseases, Yale Schools of Medicine and Public Health, New Haven, Connecticut.
³ Section of Infectious Diseases and Global Health, Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut.
⁴ Yale School of Public Health, New Haven, Connecticut.
⁵ Yale School of Management, New Haven, Connecticut.

Saad B Omer et al. JAMA. 2020.

. 2020 Nov 24;324(20):2095-2096.

doi: 10.1001/jama.2020.20892.

Saad B Omer^{1

2}, Inci Yildirim^{1

3}, Howard P Forman^{4

5}

¹ Yale Institute for Global Health, New Haven, Connecticut.
² Departments of Internal Medicine and Epidemiology of Microbial Diseases, Yale Schools of Medicine and Public Health, New Haven, Connecticut.
³ Section of Infectious Diseases and Global Health, Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut.
⁴ Yale School of Public Health, New Haven, Connecticut.
⁵ Yale School of Management, New Haven, Connecticut.

No abstract available

Comment in

High seroprevalence of SARS_COV-2 in Bergamo: evidence for herd immunity or reason to be cautious?
Signorelli C, Zucchi A, Tersalvi CA, Ciampichini R, Beato E, Balzarini F, Odone A, Middleton J. Signorelli C, et al. Int J Public Health. 2020 Dec;65(9):1815-1817. doi: 10.1007/s00038-020-01524-x. Epub 2020 Nov 20. Int J Public Health. 2020. PMID: 33216153 Free PMC article. No abstract available.